ATP11C
Phospholipid-transporting ATPase IG
Also known as: AT11C_HUMAN, ATPIG, ATPIQ
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8NB49
- Gene
- ATP11C
- Ensembl
- ENSG00000101974
- Chromosome
- X
- Canonical length
- 1132 aa
- Protein class
- Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters
OverviewNCBI Gene
Enables phosphatidylethanolamine flippase activity and phosphatidylserine flippase activity. Involved in phospholipid translocation. Located in endoplasmic reticulum and plasma membrane. Part of phospholipid-translocating ATPase complex. Implicated in X-linked congenital hemolytic anemia. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
1132 residues, UniProt reviewed canonical sequence.
>Q8NB49|ATP11C
1 MQMVPSLPPA SECAGEEKRV GTRTVFVGNH PVSETEAYIA QRFCDNRIVS SKYTLWNFLP
61 KNLFEQFRRI ANFYFLIIFL VQVTVDTPTS PVTSGLPLFF VITVTAIKQG YEDCLRHRAD
121 NEVNKSTVYI IENAKRVRKE SEKIKVGDVV EVQADETFPC DLILLSSCTT DGTCYVTTAS
181 LDGESNCKTH YAVRDTIALC TAESIDTLRA AIECEQPQPD LYKFVGRINI YSNSLEAVAR
241 SLGPENLLLK GATLKNTEKI YGVAVYTGME TKMALNYQGK SQKRSAVEKS INAFLIVYLF
301 ILLTKAAVCT TLKYVWQSTP YNDEPWYNQK TQKERETLKV LKMFTDFLSF MVLFNFIIPV
361 SMYVTVEMQK FLGSFFISWD KDFYDEEINE GALVNTSDLN EELGQVDYVF TDKTGTLTEN
421 SMEFIECCID GHKYKGVTQE VDGLSQTDGT LTYFDKVDKN REELFLRALC LCHTVEIKTN
481 DAVDGATESA ELTYISSSPD EIALVKGAKR YGFTFLGNRN GYMRVENQRK EIEEYELLHT
541 LNFDAVRRRM SVIVKTQEGD ILLFCKGADS AVFPRVQNHE IELTKVHVER NAMDGYRTLC
601 VAFKEIAPDD YERINRQLIE AKMALQDREE KMEKVFDDIE TNMNLIGATA VEDKLQDQAA
661 ETIEALHAAG LKVWVLTGDK METAKSTCYA CRLFQTNTEL LELTTKTIEE SERKEDRLHE
721 LLIEYRKKLL HEFPKSTRSF KKAWTEHQEY GLIIDGSTLS LILNSSQDSS SNNYKSIFLQ
781 ICMKCTAVLC CRMAPLQKAQ IVRMVKNLKG SPITLSIGDG ANDVSMILES HVGIGIKGKE
841 GRQAARNSDY SVPKFKHLKK LLLAHGHLYY VRIAHLVQYF FYKNLCFILP QFLYQFFCGF
901 SQQPLYDAAY LTMYNICFTS LPILAYSLLE QHINIDTLTS DPRLYMKISG NAMLQLGPFL
961 YWTFLAAFEG TVFFFGTYFL FQTASLEENG KVYGNWTFGT IVFTVLVFTV TLKLALDTRF
1021 WTWINHFVIW GSLAFYVFFS FFWGGIIWPF LKQQRMYFVF AQMLSSVSTW LAIILLIFIS
1081 LFPEILLIVL KNVRRRSARR NLSCRRASDS LSARPSVRPL LLRTFSDESN VLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ATP11C can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 10
- Mean surface accessibility (rSASA)
- 0.26
- Highest tissue expression
- 45 nTPM
Expression across tissuesHPA
Tissue
- liver: 45 nTPM
- seminal vesicle: 13 nTPM
- lymph node: 13 nTPM
- urinary bladder: 12 nTPM
- adipose tissue: 12 nTPM
- blood vessel: 12 nTPM
Single-cell type
- kupffer cells: 155 nCPM
- vascular endothelial cells: 155 nCPM
- microglia: 153 nCPM
- renal collecting duct principal cells: 128 nCPM
- early primary spermatocytes: 127 nCPM
- papillary tip epithelial cells: 120 nCPM
Immune cell
- basophil: 2.1 nTPM
- memory B-cell: 0.8 nTPM
- NK-cell: 0.8 nTPM
- MAIT T-cell: 0.6 nTPM
- naive B-cell: 0.6 nTPM
- naive CD8 T-cell: 0.6 nTPM
Brain region
- choroid plexus: 18 nTPM
- pons: 8.7 nTPM
- midbrain: 8 nTPM
- thalamus: 7.8 nTPM
- medulla oblongata: 7.2 nTPM
- hypothalamus: 7 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ATP11C.
Disease | AllUniProt
Conditions ATP11C is implicated in, by any mechanism.
- Hemolytic anemia, congenital, X-linked (HACXL) MIM:301015
Disease | GeneticClinVar
2 pathogenic / likely-pathogenic of 366 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- X-linked congenital hemolytic anemia
- Nonpapillary renal cell carcinoma
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.23
- gnomAD pLI
- 1
- gnomAD missense Z
- 1.99
- DepMap mean gene effect
- 0.01
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- ATP binding
- ATP hydrolysis activity
- ATPase-coupled intramembrane lipid transporter activity
- magnesium ion binding
- phosphatidylethanolamine flippase activity
- phosphatidylserine flippase activity
- phosphatidylserine floppase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- P-type ATPase
- P-type ATPase, subfamily IV
- P-type ATPase, A domain superfamily
- P-type ATPase, phosphorylation site
- HAD superfamily
- P-type ATPase, transmembrane domain superfamily
- P-type ATPase, cytoplasmic domain N
- P-type ATPase, C-terminal
- P-type ATPase, N-terminal
- HAD-like superfamily
- P-type ATPase, haloacid dehalogenase domain
- P-type ATPase, A domain
- P-type ATPase actuator domain
- P-type ATPase, cytoplasmic domain N
- Phospholipid-translocating ATPase N-terminal
- Phospholipid-translocating P-type ATPase C-terminal
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ATP11C in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ATP11C as an antibody target. Whether an autoantibody or antibody against ATP11C could matter depends on whether native ATP11C is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ATP11C is annotated at the cell surface, where native ATP11C is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label ATP11C as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...